| |
| |
|
| Insider
Information: |
Prendergast Franklyn G |
| Relationship: |
Director |
| City: |
Indianapolis |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
141,914 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$54,161,019 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
141,914 |
|
|
| Total
Value |
$54,161,019 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Eli Lilly & Co |
LLY |
Director |
2017-11-20 |
68,574 |
2003-11-26 |
0 |
Premium* |
|
|
Vyant Bio Ord Shs |
VYNT |
Director |
2017-09-28 |
12,500 |
2014-05-22 |
0 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-10-02 |
60,840 |
2023-10-02 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMNM |
Immunome Inc. |
Director |
– • – |
2023-10-02 |
4 |
A |
$0.00 |
$0 |
D/D |
60,840 |
60,840 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2017-11-20 |
4 |
A |
$83.18 |
$66,710 |
D/D |
802 |
68,574 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2017-09-28 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
12,500 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2017-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
10,000 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2016-11-30 |
4 |
A |
$76.64 |
$160,024 |
D/D |
2,088 |
66,904 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2016-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,500 |
7,500 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2015-11-30 |
4 |
A |
$81.23 |
$144,996 |
D/D |
1,785 |
63,139 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2014-11-28 |
4 |
A |
$67.29 |
$145,010 |
D/D |
2,155 |
59,810 |
0 |
- |
|
| VYNT |
Vyant Bio Ord Shs |
Director |
– • – |
2014-05-22 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2013-11-29 |
4 |
A |
$51.03 |
$144,976 |
D/D |
2,841 |
55,757 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2012-11-30 |
4 |
A |
$47.03 |
$144,993 |
D/D |
3,083 |
51,003 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2011-11-30 |
4 |
A |
$36.34 |
$144,997 |
D/D |
3,990 |
45,812 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2010-11-30 |
4 |
A |
$34.63 |
$144,996 |
D/D |
4,187 |
39,682 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2009-11-30 |
4 |
A |
$35.89 |
$144,996 |
D/D |
4,040 |
33,670 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2008-11-28 |
4 |
A |
$32.13 |
$145,003 |
D/D |
4,513 |
28,005 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2007-11-30 |
4 |
A |
$51.06 |
$144,996 |
D/D |
2,840 |
22,623 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2006-11-30 |
4 |
A |
$54.26 |
$144,983 |
D/D |
2,672 |
19,190 |
0 |
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2005-11-30 |
4 |
A |
$50.51 |
$75,758 |
D/D |
1,500 |
16,061 |
|
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2004-11-30 |
4 |
A |
$56.59 |
$39,613 |
D/D |
700 |
14,173 |
|
- |
|
| LLY |
Eli Lilly & Co |
Director |
– • – |
2003-11-26 |
4 |
A |
$0.00 |
$0 |
D/D |
700 |
13,208 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
